Perfusion Systems Market Size, Share & Industry Analysis, By Technique (Hypothermic, Normothermic), By Organ (Heart, Lung , Others), By Product (Cardiopulmonary Perfusion System, Extracorporeal membrane oxygenation (ECMO), Isolated Organ Perfusion Systems, Others), By End-user (Hospital, Clinic, Ambulatory Surgical Centers, Others) and Regional Forecast, 2024-2032

The process of delivery of oxygenated blood to the other tissues of the body can be characterized as perfusion. During organ transplantation operations, perfusion systems are employed to provide dynamism to the blood to flow through a web of minuscular vessels within tissues in the body, which allows the exchange of oxygen and other important molecules across semipermeable microvascular walls. Organ Perfusion Systems are devices that provide extracorporeal circulation to the patient’s organ. Increase in number of cardiovascular, renal and hepatic transplant patients is expected to boost the market.  Additionally, lack of physical exercise, smoking, and an increase in the number of alcohol consumption are further expected to propel the market.

Rising prevalence of organ transplant patients (liver transplant, and kidney transplant) and chronic diseases, growing geriatric population, increasing number of lifestyle-related disorders, and government initiatives for increasing awareness are some of the factors that are driving the market growth. According to Organ Donation and Transplantation - 2019, around 36,500 transplants were performed in 2018 in the U.S. alone, and a total of 121,678 transplantation procedures were planned out of these 100,791 were kidney transplantation procedures.

 Moreover, favorable government policies to promote public healthcare infrastructure and rising trend of automation in the treatment processes are projected to drive the market further.

However, the cost associated with treatments such as transplantation and chronic diseases is hampering the growth of the market during the forecast period.

Market Segmentation:

Globally, the perfusion systems market can be segmented on basis of technique, organs, product, end-users, and region. Based on the technique the market can be segmented into hypothermic and normothermic. Based on the organs, the market can be segmented into heart, lung, and others. Based on product the market can be segmented into cardiopulmonary perfusion systems, extracorporeal membrane oxygenation (ECMO), isolated organ perfusion systems, and others. The cardiopulmonary perfusion systems can be further categorized into oxygenation systems, heart-lung machines, cooling and heating devices, blood parameter monitoring systems, centrifugal blood pump systems, others. Based on the end users, the market can be segmented into hospital, clinic, ambulatory surgical centers, and others.

Geographically, the perfusion systems market is segmented into North America, Europe, Asia Pacific, Latin America, Middle East and Africa.

Key Players Covered:

The major companies in the global the perfusion systems market are Medtronic, GENERAL ELECTRIC COMPANY, Organ Assist Products B.V., Accuray Incorporated, Siemens Healthcare Private Limited, Shimadzu Corporation, Samsung Medison Co., Ltd., Hitachi, Ltd., XVIVO Perfusion AB, and other prominent players.

Key Insights:

• Prevalence of Chronic Diseases Key Countries/ Region


• Key Industry Developments - Mergers, Acquisitions and Partnerships


• New Product Launches


• Key Industry Developments

Regional Analysis:

Geographically, the perfusion systems market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is likely to account for the major market share is also anticipated to retain its ascendancy throughout the forecast period. The region will prove to be a lucrative market for the perfusion systems manufacturers due to enormous healthcare expenditure and advantageous health cover policies and an increase in the number of organ donors. Europe market is estimated to hold the second-largest share in the market. According to the European Commission, 70% to 80% of healthcare resources are currently being spent on chronic diseases in the European Union where perfusion systems come into play and propel the growth of the market. However, Asia-Pacific possesses the highest potential for the growth of the market due to the rise in the geriatric population, upsurge in the prevalence of chronic diseases and an increase in the purchasing power of the countries of this region. Numerous government initiatives across different countries, like national rural and urban health mission by the Indian government and Asia Health & Wellbeing Initiatives (AHWIN) by the Japanese government, are also projected to drive the market outlook over the projected timeframe

Segmentation

Perfusion Systems Market Industry Developments

• In May, 2019, Terumo Cardiovascular Group and Talis Clinical announced commercial release of the ACG-Perfusion and ACG-RemoteView Systems in North America.


• In April 2019, FDA approved Xvivo Perfusion system for its system with Steen solution perfusate.